These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1136 related articles for article (PubMed ID: 31055884)
1. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M; Zhou LY; Xu N; An Q Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884 [TBL] [Abstract][Full Text] [Related]
2. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L; Zhang J; Fan Y; Li Y Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173 [TBL] [Abstract][Full Text] [Related]
4. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A; Li H; Li R; Lu L; Wu X Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [TBL] [Abstract][Full Text] [Related]
5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
6. Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway. Gu F; Zhou Y; Tian L; Chen J; Zhang C; Huang Z; Yu W; Xie K Sci Rep; 2024 Sep; 14(1):21130. PubMed ID: 39256509 [TBL] [Abstract][Full Text] [Related]
7. Serine Protease from Chen Y; Tang Y; Tang Y; Yang Z; Ding G Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31226829 [TBL] [Abstract][Full Text] [Related]
8. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway. You J; Cheng J; Yu B; Duan C; Peng J Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297 [TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor Yellow A Promotes HaCaT Cell Proliferation and Migration by Regulating HBEGF/EGFR and PI3K/AKT Pathways and Circ_0084443. Zhang Y; Xiao YW; Ma JX; Wang AX Chin J Integr Med; 2024 Mar; 30(3):213-221. PubMed ID: 37688744 [TBL] [Abstract][Full Text] [Related]
10. Structure Identification of ViceninII Extracted from Luo Y; Ren Z; Du B; Xing S; Huang S; Li Y; Lei Z; Li D; Chen H; Huang Y; Wei G Molecules; 2019 Jan; 24(1):. PubMed ID: 30609689 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
12. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway. Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793 [TBL] [Abstract][Full Text] [Related]
13. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
14. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer. Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892 [TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway. Wang N; Feng T; Liu X; Liu Q Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070 [TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway. Su D; Lv C Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713 [TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Songyang Y; Song T; Shi Z; Li W; Yang S; Li D Gene; 2021 Feb; 768():145309. PubMed ID: 33197518 [TBL] [Abstract][Full Text] [Related]
18. SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling. Bao F; An S; Yang Y; Xu TR Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107587 [TBL] [Abstract][Full Text] [Related]
19. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253 [TBL] [Abstract][Full Text] [Related]
20. Alisol B 23‑acetate inhibits the viability and induces apoptosis of non‑small cell lung cancer cells via PI3K/AKT/mTOR signal pathway. Liu Y; Xia XC; Meng LY; Wang Y; Li YM Mol Med Rep; 2019 Aug; 20(2):1187-1195. PubMed ID: 31173235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]